Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 47

    1.

    [Assessment of primary care physicians' adherence to the national childhood vaccination schedule].

    Pruvost I, Lowingerova-Fauvet S, Debacker P, Dervaux B, Dubos F, Martinot A.

    Arch Pediatr. 2012 Mar;19(3):248-53. Epub 2012 Jan 20. French.

    PMID:
    22264997
    [PubMed - in process]
    2.

    Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

    Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

    BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

    PMID:
    22277542
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    More secrets of the MMR scare. Who saw the "histological findings"?

    Deer B.

    BMJ. 2011 Dec 7;343:d7892. doi: 10.1136/bmj.d7892. No abstract available.

    PMID:
    22162383
    [PubMed - indexed for MEDLINE]
    4.

    Amar Dhillon replies to "Pathology reports solve 'new bowel disease' riddle".

    Dhillon A.

    BMJ. 2011 Dec 7;343:d7907. doi: 10.1136/bmj.d7907. No abstract available.

    PMID:
    22162291
    [PubMed - indexed for MEDLINE]
    5.

    More secrets of the MMR scare. Where did the specimens come from?

    Tormey WP.

    BMJ. 2011 Dec 7;343:d7891. doi: 10.1136/bmj.d7891. No abstract available.

    PMID:
    22162290
    [PubMed - indexed for MEDLINE]
    6.

    H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.

    Walker WT, de Whalley P, Andrews N, Oeser C, Casey M, Michaelis L, Hoschler K, Harrill C, Moulsdale P, Thompson B, Jones C, Chalk J, Kerridge S, John TM, Okike I, Ladhani S, Tomlinson R, Heath PT, Miller E, Faust SN, Snape MD, Finn A, Pollard AJ.

    Clin Infect Dis. 2012 Mar 1;54(5):661-9. Epub 2012 Jan 19.

    PMID:
    22267719
    [PubMed - in process]
    Free PMC Article
    7.

    A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.

    Ehrlich HJ, Singer J, Berezuk G, Fritsch S, Aichinger G, Hart MK, El-Amin W, Portsmouth D, Kistner O, Barrett PN.

    Clin Infect Dis. 2012 Apr;54(7):946-54. Epub 2012 Jan 19.

    PMID:
    22267715
    [PubMed - in process]
    Free PMC Article
    8.

    Recurrent Guillain-Barre syndrome following vaccination.

    Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network.

    Clin Infect Dis. 2012 Mar;54(6):800-4. Epub 2012 Jan 19.

    PMID:
    22267712
    [PubMed - in process]
    9.

    Infant pertussis: is cocooning the answer?

    Munoz F, Englund J.

    Clin Infect Dis. 2011 Nov;53(9):893-6. Epub 2011 Sep 26. No abstract available.

    PMID:
    21946188
    [PubMed - indexed for MEDLINE]
    10.

    Exposure to nicotine adversely affects the dendritic cell system and compromises host response to vaccination.

    Nouri-Shirazi M, Guinet E.

    J Immunol. 2012 Mar 1;188(5):2359-70. Epub 2012 Jan 25.

    PMID:
    22279108
    [PubMed - indexed for MEDLINE]
    11.

    Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis.

    Kochetkova I, Thornburg T, Callis G, Pascual DW.

    J Immunol. 2011 Nov 1;187(9):4654-66. Epub 2011 Oct 3.

    PMID:
    21967895
    [PubMed - indexed for MEDLINE]
    12.

    Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.

    O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, Goodman AL, Edwards NJ, Reyes-Sandoval A, Bird P, Rowland R, Sheehy SH, Poulton ID, Hutchings C, Todryk S, Andrews L, Folgori A, Berrie E, Moyle S, Nicosia A, Colloca S, Cortese R, Siani L, Lawrie AM, Gilbert SC, Hill AV.

    J Infect Dis. 2012 Mar;205(5):772-81. Epub 2012 Jan 24.

    PMID:
    22275401
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

    El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, Johnston C, George SL, Brady RC, Lehmann C, Stokes-Riner A, Keitel WA.

    J Infect Dis. 2012 Mar;205(5):703-12. Epub 2012 Jan 24.

    PMID:
    22275399
    [PubMed - indexed for MEDLINE]
    14.

    More lessons from the Taiwanese hepatitis B virus vaccine program.

    Schwarz KB.

    J Infect Dis. 2012 Mar;205(5):702. Epub 2012 Jan 19. No abstract available.

    PMID:
    22262789
    [PubMed - indexed for MEDLINE]
    15.

    Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.

    Chang SJ, Shih AC, Tang YL, Chang W.

    J Virol. 2012 Apr;86(7):3809-18. Epub 2012 Jan 25.

    PMID:
    22278246
    [PubMed - in process]
    16.

    Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.

    Terajima M, Cruz J, Co MD, Lee JH, Kaur K, Wrammert J, Wilson PC, Ennis FA.

    J Virol. 2011 Dec;85(24):13463-7. Epub 2011 Oct 12. Erratum in: J Virol. 2012 Feb;86(3):1901. Wrammert, Jens [added].

    PMID:
    21994454
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.

    Longet S, Schiller JT, Bobst M, Jichlinski P, Nardelli-Haefliger D.

    J Virol. 2011 Dec;85(24):13253-9. Epub 2011 Oct 5.

    PMID:
    21976653
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

    Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C.

    JAMA. 2012 Jan 25;307(4):391-7. Erratum in: JAMA. 2012 Mar 21;307(11):1142.

    PMID:
    22274686
    [PubMed - indexed for MEDLINE]
    19.

    Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study.

    Santolaya ME, O'Ryan ML, Valenzuela MT, Prado V, Vergara R, Muñoz A, Toneatto D, Graña G, Wang H, Clemens R, Dull PM; V72P10 Meningococcal B Adolescent Vaccine Study group.

    Lancet. 2012 Feb 18;379(9816):617-24. Epub 2012 Jan 18.

    PMID:
    22260988
    [PubMed - indexed for MEDLINE]
    20.

    Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):55-6.

    PMID:
    22278160
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk